Abstract
Purpose
Cysticercosis is the presence of Taenia solium larvae in humans or swines tissues. It is a public health problem related to bad hygienic habits and consumption of infected pork. T. crassiceps is a widely used cysticercosis experimental model. The combination of two effective drugs such as nitazoxanide (NTZ) and flubendazole (FBZ) may potentialize their effect. The aim of this study was to use biochemical analysis to determine the metabolic impact of the combination of NTZ and FBZ on cysticerci inoculated intraperitoneally in mice.
Methods
Balb/c mice intraperitoneally infected with T. crassiceps cysticerci received a single oral dose NTZ/FBZ (50 mg/kg). 24 h after the treatment the cysticerci were removed, frozen and analyzed by high performance liquid chromatography regarding the detection of the following metabolic pathways: glycolysis, gluconeogenesis, homolactic fermentation, tricarboxylic acid cycle, proteins catabolism and fatty acids oxidation.
Results
The treatment with the drugs combination induced a statistically significant increase in gluconeogenesis and in protein catabolism when compared to the control groups.
Conclusion
The drugs combination is potentialized and capable of causing greater metabolic stress than the separate treatment with NTZ or FBZ, showing its potential for an alternative cysticercosis treatment.
Similar content being viewed by others
Availability of Data and Material
All data and materials are available at the Tropical Pathology and Public Health Institute, Federal University of Goias.
References
Carabin H, Winkler AS, Dorny P (2017) Taenia solium cysticercosis and taeniosis: achievements from the past 10 years and the way forward. PLoS Negl Trop Dis 11:e0005478. https://doi.org/10.1371/journal.pntd.0005478
World Health Organization (2019) Taeniasis/cysticercosis factsheet. WHO news room, World Health Organization, Geneva. https://www.who.int/news-room/fact-sheets/detail/taeniasis-cysticercosis. Accessed 15 Jun 2019. (Published on 21st of May 2019)
Chembensofu M, Mwape KE, Van Damme I, Hobbs E, Phiri IK, Masuku M, Zulu G, Colston A, Willingham AL, Devleesschauwer B, Van Hul A, Chota A, Speybroeck N, Berkvens D, Dorny P, Gabriel S (2017) Re-visiting the detection of porcine cysticercosis based on full carcass dissections of naturally Taenia solium infected pigs. Parasit Vectors 10:572. https://doi.org/10.1186/s13071-017-2520-y
Johansen MV, Trevisan C, Gabriel S, Magnussen P, Braae UC (2017) Are we ready for Taenia solium cysticercosis elimination in sub-Saharan Africa? Parasitology 144:59–64. https://doi.org/10.1017/S0031182016000500
James CE, Hudson AL, Davey MW (2009) Drug resistance mechanisms in helminths: is it survival of the fittest? Trends Parasitol 25(7):328–335. https://doi.org/10.1016/j.pt.2009.04.004
Loker ES (2015) This de-wormed world? J Parasitol 99:933–942. https://doi.org/10.1645/13-390.1
Mkupasi EM, Sikasunge CS, Ngowi HA, Johansen MV (2013) Efficacy and safety of anthelmintics tested against Taenia solium cysticercosis in pigs. PLoS Negl Trop Dis 7:e2200. https://doi.org/10.1371/journal.pntd.0002200
Ng-Nguyen D, Noh J, Breen K, Stevenson MA, Handali S, Traub RJ (2018) The epidemiology of porcine Taenia solium cysticercosis in communities of the Central Highlands in Vietnam. Parasit Vectors 11:360. https://doi.org/10.1186/s13071-018-2945-y
Lacey E (1990) Mode of action of benzimidazoles. Parasitol Today 6:112–115. https://doi.org/10.1016/0169-4758(90)90227-U
Cumino AC, Elissondo MC, Denegri GM (2009) Flubendazole interferes with a wide spectrum of cell homeostatic mechanisms in Echinococcus granulosus protoscoleces. Parasitol Int 58:270–277. https://doi.org/10.1016/j.parint.200
Geary TG, Mackenzie CD, Silber SA (2019) Flubendazole as a macrofilaricide: history and background. PLoS Negl Trop Dis 13:e0006436. https://doi.org/10.1371/journal.pntd.0006436
Gilles HM, Hoffman PS (2002) Treatment of intestinal parasitic infections: a review of nitazoxanide. Trends Parasitol 18:95–97. https://doi.org/10.1016/S1471-4922(01)02205-X
Shakya A, Bhat HR, Ghosh SK (2018) Update on nitazoxanide: a multifunctional chemotherapeutic agent. Curr Drug Discov Technol 15:201–213. https://doi.org/10.2174/1570163814666170727130003
De Lange A, Mahanty S, Raimondo JV (2019) Model systems for investigating disease processes in neurocysticercosis. Parasitology 146:553–562. https://doi.org/10.1017/s0031182018001932
Maldonado G, Nava G, Plancarte A (2018) Two glutathione transferase isoforms isolated from juvenile cysts of Taenia crassiceps: identification, purification and characterization. J Helminthol 92:687–695. https://doi.org/10.1017/S0022149X17000931
Vaz AJ, Nunes CM, Piazza RM, Livramento JA, Da Silva MV, Nakamura PM (1997) Immunoblot with cerebrospinal fluid from patients with neurocysticercosis using antigen from cysticerci of Taenia solium and Taenia crassiceps. Am J Trop Med Hyg 57:354–357. https://doi.org/10.4269/ajtmh.1997.57.354
Vinaud MC, Lino Junior RS, Bezerra JCB (2007) Taenia crassiceps organic acids detected in cysticerci. Exp Parasitol 116:335–339. https://doi.org/10.1016/j.exppara.2007.01.013
Nasareth JM, Fraga CM, Lima NF, Picanço GA, Costa TL, Lino-Junior RS, Vinaud MC (2017) In vivo treatment with nitazoxanide induces anaerobic metabolism in experimental intraperitoneal cysticercosis. Parasitol Res 116:3037–3041. https://doi.org/10.1007/s00436-017-5614-8
Picanço GA, Lima NF, Fraga CM, Costa TL, Isac E, Ambrosio J, Castillo R, Vinaud MC (2017) A benzimidazole derivative (RCB15) in vitro induces the alternative energetic metabolism and glycolysis in Taenia crassiceps cysticerci. Acta Trop 176:288–292. https://doi.org/10.1016/j.actatropica.2017.08.022
Lima NF, Picanço GA, Alves DSMM, Silva LD, Isac E, Costa TL, Lino Junior RS, Vinaud MC (2019) Oral nitazoxanide treatment of experimental neurocysticercosis induces gluconeogenesis in Taenia crassiceps cysticerci. Acta Trop 190:361–364. https://doi.org/10.1016/j.actatropica.2018.12.017
Fraga CM, Costa TL, Bezerra JCB, Lino-Junior RS, Vinaud MC (2012) Taenia crassiceps: host treatment alters glycolisis and tricarboxilic acid cycle in cysticerci. Exp Parasitol 130:146–151. https://doi.org/10.1016/j.exppara.2011.11.001
McCracken RO, Lipkowitz KB (1990) Structure-activity relationships of benzothiazole and benzimidazole anthelmintics: a molecular modeling approach to in vivo drug efficacy. J Parasitol 76(6):853–864
Maslowski KM (2019) Metabolism at the centre of the host-microbe relationship. Clin Exp Immunol 197(2):193–204. https://doi.org/10.1111/cei.13329
Barragry T (1984) Anthelmintics—a review. N Z Vet J 32(10):161–164. https://doi.org/10.1080/00480169.1984.35109
Corbin I, Simcoff R, Novak M, Blackburn BJ (1998) Metabolism of [3-(13)C]-pyruvate by cysticerci of Taenia crassiceps. Parasitol Res 84:516–518. https://doi.org/10.1007/s004360050439
Tielens AGM (1994) Energy generation in parasitic helminths. Parasitol Today 10:346–352. https://doi.org/10.1016/0169-4758(94)90245-3
Tkachuck RD, Saz HJ, Weinstein PP, Finnegan K, Mueller JF (1977) The presence and possible function of methylmalonyl-CoA and propionyl-CoA carboxylase in Spirometra mansonoides. J Parasitol 63:769–774
Vinaud MC, Ferreira CS, Lino Júnior RS, Bezerra JCB (2009) Taenia crassiceps: fatty acids oxidation and alternative energy source in vitro cysticercoci exposed to anthelminthic drugs. Exp Parasitol 122:208–211. https://doi.org/10.1016/j.exppara.2009.03.015
Cvilink V, Lamka J, Skálová L (2009) Xenobiotic metabolizing enzymes and metabolism of anthelminthics in helminths. Drug Metab Rev 41(1):8–26. https://doi.org/10.1080/036025308026028809.03.005
Tielens AGM, van Grinsven KWA, Henze K, van Hellemond JJ, Martin W (2010) Acetate formation in the energy metabolism of parasitic helminths and protists. Int J Parasitol 40:387–397. https://doi.org/10.1016/j.ijpara.2009.12.006
Funding
This work was supported by the National Council for Scientific and Technological Development (CNPq) (grant numbers 302159/2016-9, 301822/2019-0).
Author information
Authors and Affiliations
Contributions
NFL designed the work, data acquisition, analysis and interpretation; GAP and TLC performed data acquision and analysis; RSLJ critical review of the manuscript, MCV conception and design of the work, interpretation of the data, drafting and final approval of the version to be published.
Corresponding author
Ethics declarations
Conflict of Interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethics Approval
The Ethics Committee in Animal Use of the Federal University of Goias (CEUA/UFG) approved this study under the protocol number 048/17.
Rights and permissions
About this article
Cite this article
Lima, N.F., Picanço, G.A., Costa, T.L. et al. In Vivo Treatment with the Combination of Nitazoxanide and Flubendazole Induces Gluconeogenesis and Protein Catabolism in Taenia crassiceps cysticerci. Acta Parasit. 66, 98–103 (2021). https://doi.org/10.1007/s11686-020-00263-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11686-020-00263-6